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Summary The continuous cell line UCRU BL 17CL was derived from a human invasive bladder cancer and
expresses elements of transitional, squamous and glandular differentiation. Nine clones of this line were
established by limit dilution and have been extensively characterised. Only six of these clones grew sub-
cutaneously in nude mice. Of these, three have exhibited local invasion, each in one of five implanted mice.
Although all xenografts expressed transitional, squamous and glandular elements, different histological sub-
types predominated within each clone. Only clones which grew in nude mice formed colonies in semi-solid
medium, and each responded differently to the influence of medium that had been conditioned by the growth
of UCRU BL 17CL, suggesting the possible secretion of a growth factor by these cells. The DNA content and
lectin binding profiles of the clones also reflected the heterogeneity of the line. UCRU BL 17CL and the nine
clones provide a unique model for the study of tumour heterogeneity, progression and differentiation, and the
potential autocrine regulation of growth of bladder cancer.
In human bladder cancer, and in many other cancer types,
the cell population within a single neoplasm is often
heterogeneous. Tumours which appear homogeneous by light
microscopy may contain cells with very different abilities to
invade or metastasise or with varying degrees of sensitivity to
cytotoxic agents and irradiation. Tumour progression (the
evolution of the cells from a normal through to a malignant,
more aggressive state) and the development of genetic in-
stability are two factors which may give rise to tumour
heterogeneity (Heppner, 1984). The establishment of in vitro
cell lines derived from human cancers provides a model for
the study of tumour progression and heterogeneity.
More than 30 cell lines have been established from human
transitional cell carcinoma of the bladder (Lin et al., 1985).
Although many of these lines have been extensively studied,
there have been few reports of the isolation and characterisa-
tion of individual cell subpopulations within them (Hastings
& Franks, 1983; Lin et al., 1985; Masters et al., 1986; Kovnat
et al., 1988).
The continuous cell line UCRU BL 17CL was established
from a human invasive (stage T4b) transitional cell car-
cinoma of the bladder (Russell et al., 1988a). The line, when
grown either in vitro or as xenografts in nude mice, expresses
features of transitional, squamous and glandular
differentiation (Russell et al., 1988a, b). The histological and
functional heterogeneity of this line in vitro has led to
attempts to develop a series of cloned sublines of UCRU BL
17CL in order to determine whether the heterogeneity is due
to the presence of different subpopulations or is inherent in
the nature of the stem cells.
This report describes the development and extensive char-
acterisation of nine clones of UCRU BL 17CL. We propose
that this model illustrates the phenomonen of tumour
heterogeneity, and provides a useful system for the study of
tumorigenicity, tumour differentiation and progression, and
sensitivity to treatment.
Materials and methods
Cell line
The line UCRU BL 17 was derived from a grade III, stage
T4b transitional cell carcinoma of the bladder. The tumour
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was resistant to cisplatin and radiotherapy, and the patient
died 4 months after presentation. The continuous cell line,
UCRU BL 17CL, was derived from a xenograft established
by implantation of a biopsy specimen, taken before treat-
ment, into nude mice. The line produces mucin in vitro, and
contains some cells expressing features of both squamous and
glandular differentiation within the same cell (Russell et al.,
1988a, b).
Cell cultures
All cell lines were maintained as previously described (Russell
et al., 1988a), but in a less complex culture medium: RPMI
1640 (Flow Laboratories, Australia), supplemented with
0.21% sodium bicarbonate, 4mM L-glutamine (Flow
Laboratories) and 10% fetal calf serum (CSL, Australia and
Cytosystems, Australia) heated to 56'C for 30min.
Establishment ofcloned sublines of UCRU BL 17CL
For limit dilution adherent UCRU BL 17CL were harvested
with ImM EDTA (Flow Laboratories) at 37'C for 1-2 h.
The cells were incubated on ice for 60 min with the mono-
clonal antibody, CaOvl (kindly provided by G. Hayden,
Clinical Immunology Research Centre, University of
Sydney), raised against a panel of ovarian carcinoma cell
lines and known to be reactive against UCRU BL 17CL cells
(G. Hayden & K.Z. Walker, personal communication).
Fluorescein conjugated sheep anti-mouse immunoglobulin
(affinity purified FITC-SxMIg, diluted 1/50, Silenus, Aus-
tralia) was used as a second antibody. This enabled the cells
to be sorted on a fluorescence activated cell sorter (FACS).
Green fluorescence was assessed by flow cytometric analysis
on a FACS 440 (Becton Dickinson, Sunnyvale, CA, USA)
using the 488 nm line of an argon ion laser (200mW).
Positive cells (two cells per well) were sorted into the wells of
a 96-well plate (Flow Laboratories) filled with 0.25 ml of
culture medium per well. Due to methodological problems,
negative cells could not be sorted at this time. The number of
cells per well was assessed under a phase contrast microscope
and no wells were found to contain greater than two cells.
Incubation was continued until cell proliferation was
observed (approximately 2 weeks). Fourteen wells exhibiting
cell growth were detected. From the frequency of positive
wells and assuming random sorting, by the Poisson distribu-
tion these wells can be considered to contain clones (Lef-
kovits & Waldmann, 1984). Nine cell lines were established
from nine of the 14 wells.
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Isozyme analysis
Cultured cells were harvested with 0.25% trypsin, and
suspended in 20mM Tris.HC1 pH7.5, 1% Triton X-100
(100f1 per 107 cells). The suspension was incubated on ice
for 20min. After centrifugation at 1,000g the supernatent
was taken and stored at -70°C until analysed. Lactate
dehydrogenase (LDH) isozymes were analysed using elect-
rophoresis by Dr Peter Stewart, Department of Biochemistry,
Royal Prince Alfred Hospital, Sydney.
Growth assay in vitro
For each cell line, thirty 25 cm' tissue culture flasks (Corning,
Australia) were seeded with 5 x 104 cells per flask, and
incubated in 5% 02- Cells from duplicate flasks were
harvested with 0.25% trypsin (Cytosystems) and counted
every second or third day until all flasks had been used. For
each cell line at least five points were obtained while the cells
were in an exponential phase of growth. Population doubling
times were estimated after linear regression analysis of the
data obtained.
Anchorage independent growth
Anchorage independent growth of cell lines was examined by
the method of Hamburger and Salmon (1977). Briefly, under-
layers of 0.5% agar in culture medium were established in
six-well plates (35 mm2 wells) (Flow Laboratories). Serial
dilutions of trypsin harvested cells were suspended in 0.8%
methylcellulose (Sigma, St Louis, MO, USA) in culture
medium, and plating layers of 1 ml were poured over the
preset agar underlayers in duplicate. The cultures were
incubated in 5% 02 for 14 days. Colonies containing more
than 20 cells were counted under a phase contrast microscope
and the colony forming efficiency of each cell line was cal-
culated as the mean of the percentage of colonies formed per
number of cells plated for each well.
UCRU BL 17CL conditioned medium and colonyforming
efficiency
The effect of UCRU BL 17CL conditioned medium on the
colony forming efficiency of the cell lines was tested. The
medium from a 70-80% confluent culture of UCRU BL
17CL was collected and non-adherent cells removed by cent-
rifugation. The supernatant was filtered through a 0.2 gsm
filter unit (Millipore Products Division, Bedford, MA, USA)
to ensure the removal of any residual tumour cells. The
conditioned medium was used on the same day as prepared
and was included in both underlayers and plating layers at a
concentration of 30% v/v. Colony forming assays with and
without UCRU BL 17CL conditioned medium for each clone
were studied in parallel to allow the direct comparison of
results.
DNAflow cytometry
Cells from tissue culture were stained in a solution of 1% v/v
Triton X-100 (Packard, Downers Grove, IL, USA) contain-
ing 50tsg ml-' propidium iodide (Calbiochem, San Diego,
CA, USA) and 800tLg ml-' Ribonuclease A (Sigma), and
their DNA content was analysed using a FACS 440 (Becton
Dickinson) with an argon ion laser excitation source at
488 nm (400 mW). A 620 nm long pass filter was used to
collect the propidium iodide fluorescence. Chick blood cells
were included in each sample as an internal standard to
exclude staining and instrumental variability. The chick
blood cell DNA peak was set at channel 15, and the data
obtained analysed using a Consort 40 (Becton Dickinson).
Lectin binding analysis
Tissue culture cells were harvested by EDTA treatment and
incubated with fluoresceinated lectins, and green fluorescence
was assesed on a FACS 440 (Becton Dickinson) as previously
described (Russell et al., 1988c). Negative controls were
assessed following binding of the lectin in the presence of the
appropriate inhibiting sugar at a final concentration of
0.62 mM for N, N', N"-triacetylchitotriose and 0.2 M for the
remaining sugars. The lectins studied and the inhibitor for
each were Jack Bean meal (Conconavalin A) (Con A) with
mannose, Osage Orange (Maclura pomifera) (MPA) with
D-galactose, peanut agglutinin (Arachis hypogaea) (PNA)
with D-galactose, soy bean agglutinin (Glycine max) (SBA)
with D-galactose, Gorse agglutinin (Ulex europaeus) (UEA)
with fucose, and wheatgerm agglutinin (Triticum vulgaris)
(WGA) with N,N',N"-triacetylchitotriose. All lectins were
obtained from E-Y Laboratories (San Mateo, CA, USA).
Binding intensity was quantified as the difference in peak
channel fluoresence (measured on a log scale) in the absence
and in the presence of the inhibiting sugar.
Growth in vivo
Male BALB/c nu/nu ('nude') mice (Australian Atomic
Energy Commission, Lucas Heights, NSW, Australia) were
used to study the tumorigenicity of the cell lines. Their
husbandry and maintenance have been reported previously
(Russell et al., 1988b). Tissue culture cells were injected sub-
cutaneously over the scapular region of the nude mouse. For
each line five mice were injected and each mouse received
5 x 10' cells in 0.1 ml phosphate buffered saline. Tumour
growth was monitored twice weekly for periods up to 8
months. Opposite diamters (D, and D2) were measured with
calipers and the tumour volume (V) calculated by the for-
mula (Kovnat et al., 1982):
V = R/6 (D,. D2)31/2
Light microscopy
Fragments of xenografted tumours were fixed in 10%
buffered formalin, embedded in paraffin, sectioned and
stained with haematoxylin and eosin, and with periodic acid
Schiff plus diastase, mucicarmine and alcian blue for mucins.
Tissue culture cells were grown to 70% confluence in slide
chambers (LabTek Division, Miles Laboratories Inc., Naper-
ville, IL, USA), fixed in 95% ethanol and tested for the
presence of mucins with the stains listed above.
Results
Establishment ofcloned cell lines
Approximately 60% of UCRU BL 17CL cells (passage 15)
were positive for the CaOvl antigen (data not shown). Each
well of a 96-well plate was seeded with two cells positive for
the antigen using a fluorescence activated cell sorter. After
two weeks, 14 wells were found to contain proliferating cells.
The cells in one well stopped proliferating before reaching
confluence. A further four wells were lost by bacterial con-
tamination. The clones from the remaining nine wells were
expanded into cell lines. Each cell line has been through at
least 40 passages.
The nine clones, named according to the position of the
well from which they were derived (vertical letter and
horizontal number), and the parent cell line, UCRU BL
17CL, were later tested (10-15 passages after the limit dilu-
tion assay) for the presence of CaOvl antigen expression so
that the negative cells could be sorted. None of the cell lines
expressed the antigen at this later stage, suggesting that the
antigen is transiently expressed in prolonged culture.
Isozyme analysis
All of the cell lines tested contained only human LDH
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UCRU BL 17CL cell lines (data not shown). Very little LD1
(0-4% of total LDH) and increasing amounts of LD2 to
LD5 were present in the lines. The major LDH isozyme in
each of the UCRU BL 17CL cell lines was LD5 (27.5-65.7%
of total LDH).
Growth in vitro
All of the clones had similar growth curves (data not shown)
with doubling times ranging from 1.6 to 2.5 days. UCRU BL
17CL, the parent cell line, had the longest population doub-
ling time of 2.7 days (Table I). These results were found to
be reproducible for UCRU BL 17CL and three of the nine
cloned cell lines (B9, B1O and B12). Growth assays for the
other six clones were not repeated.
The morphology of UCRU BL 17CL 'parent' cells in vitro
is described in detail elsewhere (Russell et al., 1988a). Briefly,
the cultures contained a mixture of islets of polygonal
epithelial cells, and single cells which were either spindle
shaped or rounded (Figure la). Clones B8, B1O, B12 and D2
consisted of polygonal, closely apposed cells only (Figure
lb). Clone CIO had a similar morphology but with smaller
cells than in these four clones (Figure lc). The remaining
four clones, B9, Bl1, Cl and C3, contained some smaller
polygonal cells, but predominantly consisted of more
rounded cells, which remained separate from each other and
appeared more loosely organised (Figure ld).
Clones B9, B10, BI 1, C10 and D2 were grown in slide
chambers and stained to detect mucins. No mucin production
was observed in clones B9 or B10. Positive staining was
observed in a small number of cells of the other three clones.
Anchorage independent growth
The clones Bl1, C3 and CIO did not form colonies in
methylcellulose, whereas the remaining clones and the parent
line, UCRU BL 17CL, did grow in methylcellulose, with
colony forming efficiencies ranging from 0.2 to 2.4% (Table
I). The effect of 30% UCRU BL 17CL conditioned medium
in this assay is shown in Table I. Clones Bl 1, C3 and C1O
showed no response to the conditioned medium, their colony
forming efficiencies remaining zero. Clones B8, B9 and B1O
(with high colony forming efficiencies of 2.3, 1.8 and 1.9%
respectively) also had no response to the added medium. In
contrast, the conditioned medium increased the colony form-
ing efficiency between 5- and 20-fold in clones B12, Cl and
D2 and the parent cell line UCRU BL 17CL.
In each case colony formation was linearly related to the
cell number plated. No enhancement of colony formation
was observed at high cell densities within the range of cell
numbers used.
DNAflow cytometry
All the clones and UCRU BL 17CL contained both diploid
and tetraploid populations (Figure 2a and Table I), with
greater than 10% of cells in the DNA synthetic (S) phase of
the cell cycle. Clones B1O, B12 and D2 in addition contained
a triploid component (Figure 2b and Table I). The percent-
age of S phase cells in the clones ranged between 13.6 and
32.6, with that of UCRU BL 17CL being 21.7% (Table I). The ploidy of the cell lines observed by cytogenetic analysis
agreed with these results. Only human karyotypes were
obtained, the details of which will be reported elsewhere.
Lectin binding analysis
The cell surface lectin binding profiles for the lectins WGA,
PNA and MPA were similar for all of the clones (Table II).
Some heterogeneity was observed in the binding of SBA,
UEA and ConA to the cell lines (Figure 3), with the binding
profiles for ConA showing the most marked heterogeneity.
Growth in vitro
Clones Bl 1, C3 and C1O did not form tumours when injected
subcutaneously into nude mice. The other six clones and the
parent cell line grew subcutaneously in nude mice. The
tumour volume doubling times varied between the clones,
ranging from 2.6 to 15 days. By light microscopy all of the
tumours were grade III transitional cell carcinomas and all
contained elements of adenocarcinoma and squamous cell
carcinoma; however, the proportions of these elements varied
between the clones (Table I). In clone B1O squamous cell
carcinoma predominated and very little adenocarcinoma was
present (Figure 4a), whereas B12 contained mainly adenocar-
cinoma (Figure 4b). Although both histological types were
present in clones B8 and B9, squamous cell carcinoma again predominated. UCRU BL 17CL and clones Cl and D2
contained elements of both (Figure 4c).
No clinical indication of metastatic disease was observed
for any of the clones. However, at autopsy and by light microscopic inspection three of the clones appeared to invade
local tissues, each in one of five implanted mice. Clone B8
invaded the muscle surrounding the shoulder joint, B9
invaded the ribs (Figure 5a) and B1O invaded the superficial muscle of the lateral chest wall (Figure Sb). Haematoxylin and eosin stained sections of the B9 tumour contained what
appeared to be activated osteoclasts and osteoblasts (Figure 5a). No macroscopic evidence of invasion was seen in xeno-
grafts of the remaining clones.
Discussion
The phenomonen of tumour heterogeneity in human bladder
cancer may be a consequence of tumour progression (Hepp-
ner, 1984). As the urothelial cells evolve from the normal,
through an immortalised, benign state, to a malignant, more
aggressive phenotype, the complexity of the cell population increases. Previous characterisation of the human bladder
cancer cell line, UCRU BL 17CL, has demonstrated tumour
Table I Growth characteristics of URCU BL 17CL cell lines
Colonyforming efficiency Doubling time
- CM + CM In vitro In vivo
(%) (%) (days) (days)
Macroscopic invasion
(predom. histological
subtype*) Ploidy S phase (%) UCRU BL 17CL 0.3 ± 0.1 4.1 ± 0.2 2.7 10.0 - (adca + sqcca) 2n, 4n 21.7 Clone B8 2.3 ± 0.1 2.4 ± 0.2 2.1 7.0 + (sqcca) 2n, 4n 13.6 B9 1.8 0.1 1.9 ± 0.3 2.0 15.0 + (sqcca) 2n, 4n 18.3 B1O 1.9 0.3 2.0± 0.2 1.6 7.0 + (sqcca) 2n, 3n, 4n n.d. Bll 0 0 2.4 - 2n,4n 19.7 B12 0.2 ± 0.1 1.0 ± 0.1 2.1 2.5 -(adca) 2n, 3n, 4n n.d. Cl 0.1 ± 0.0 3.4 ± 0.5 2.5 9.0 -(adca + sqcca) 2n, 4n 24.5 C3 0 0 2.1 - 2n, 4n 19.0 CIO 0 0 2.5 - - 2n, 4n 32.6 D2 1.1 ± 0.3 6.2 ± 0.5 1.6 7.0 - (adca + sqcca) 2n, 3n, 4n n.d.
CM, UCRU BL 17CL conditioned medium; sqcca, squamous cell carcinoma; adca, adenocarcinoma; n.d., not determined. *AlI xenografts were transitional cell carcinoma grade III with either adca or sqcca predominating.
Cell line372 J.L. BROWN et al.
Figure I Reverse phase photomicrographs of: a, UCRU BL
I7L b c BD.
17CL; b, clone B8; c, clone CIO; d, clone C3 in tissue culture.
heterogeneity. However, the study of the constituent cell
populations as one unit restricts the number of indices of
tumour biology that can be examined for heterogeneity. To
overcome this problem, subpopulations of UCRU BL 17CL
have been isolated. UCRU BL 17CL cells have been shown
to sort randomly in a limit dilution assay. That is, the
frequency of wells containing proliferating cells is linearly
related to the number of cells plated per well, with the
frequency doubling when twice the number of cells are
plated. Thus Poisson statistics apply, and the UCRU BL
17CL sublines can be considered clones (Lefkovits & Wald-
mann, 1984).
The inability of three of the clones to form tumours in
nude mice may be inherent in these cells, and these lines mayCLONAL ANALYSIS OF BLADDER CANCER CELL LINE 373
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Figure 2 Representative DNA histograms of a, clone B8, and b,
clone B12. Arrows indicate the positions of the different com-
ponents: )- 2n; ----* 3n; ..* 4n. Peak c represents the DNA
component of the chick blood cells.
represent cells in an early stage of tumour progression;
immortal, non-malignant cell subpopulations. Similarly,
those clones which are tumorigenic in nude mice may repre-
sent cells in a later stage of tumour progression. Similar
heterogeneity to that observed in the tumorigenicity of the
UCRU BL 17CL clones in the nude mouse (Table I) has
been observed in clones of other bladder cancer cell lines
(Masters et al., 1986; Flatlow et al., 1987).
Although the UCRU BL 17CL cell lines are clonal, when
grown in tissue culture and as xenografts in the nude mouse
the cell populations within each clone express mixed patterns
of morphological differentiation, the proportion of which
vary between the clones. The mixed pattern may result from
the proliferation of both cell types in the original well of the
limit dilution assay. However, we believe this to be very
unlikely since by Poisson statistics the probability of this
occuring is very low. The proportion of histological subtypes
which occur in the xenografts of each clone is constant for
each tumour derived from that clone. This observation sug-
gests that the ability of the cloned cell lines to display a
mixed but constant pattern of differentiation features must be
inherent in the individual cell lines and supports our previous
postulate that transitional, squamous and glandular
differentiation in the urothelium all arise from a common
stem cell (Russell et al., 1988b).
In bladder cancer the presence of aneuploid cell popula-
tions usually correlates with tumour aggression, the most
invasive tumours often containing a triploid DNA compo-
nent (Blomjous et al., 1988; Tribukait, 1984). The original
tumour from which UCRU BL 17CL was derived was ag-
gressive in its behaviour, resulting in the death of the patient
only four months after presentation (Russell et al., 1988a).
However, the tumour contained mainly diploid cells with a
minor tetraploid population (Russell et al., 1988a). All the
UCRU BL 17CL clones contained both 2n and 4n DNA
components. Three contained additional triploid components
(Table I). The triploid cells may have arisen in vitro or may
represent a population of cells which were present in low
numbers in the original tumour but expanded by the cloning
of the cell line. The presence of the triploid component did
not correlate with local invasion in the nude mouse, nor with
lectin binding, nor with colony formation in vitro. However,
it has previously been shown that the subcutaneous growth
of human tumours in the nude mouse is not the optimal
model for the investigation of tumour aggression (Sharkey &
Fogh, 1979). Cells implanted subcutaneously usually form
relatively benign tumours (Sharkey & Fogh, 1979; Ahlering
et al., 1987), the site of implantation influencing whether or
not the tumour will invade or metastasise (Morikawa et al.,
1988). In order to study the mechanisms of invasion and
metastasis of bladder tumours, human bladder cancer cells
are being implanted in the bladder wall of nude mice. It has
been proposed that this model more closely represents the
situation in the patient (Ahlering et al., 1987).
An unexpected result was the lack of correlation between
the growth rates determined in vitro and the percentage of
cells in S-phase determined by DNA flow cytometry for each
cell line. This lack of correlation may reflect differences in the
cell cycles of the lines studied. Detailed cell cycle analysis has
not been performed.
Heterogeneity of lectin binding in sections of individual
bladder tumours has been observed by others (Neal et al.,
1987). A high level of WGA, PNA and ConA binding, and a
reduction in UEA binding, appears to correlate with high
grade, invasive bladder cancers (Neal et al., 1987; Caselitz,
1987). However, the variation observed in the cell surface
lectin binding profiles of the UCRU BL 17CL clones has not
correlated with other characteristics of the clones studied in
this report. Indeed, clone B9, which was invasive in one of
five nude mice, showed very strong binding of UEA (Table
II).
Anchorage independent growth of the clones appears to
correlate with their tumorigenicity in nude mice. Only those
clones which grow subcutaneously in nude mice form col-
onies in methylcellulose. Others have noted a similar correla-
tion (Freedman & Shin, 1974). Colony forming efficiencies of
the clones are within the ranges previously found for cell
lines derived from bladder tumours (Hastings & Franks,
1983; Heckl et al., 1988) and bladder tumour cell suspensions
(Kovnat et al., 1984.)
The cell line 647V, also derived from a human transitional
cell carcinoma of the bladder, was shown to produce a
substance which stimulated the growth of 647V cells (Mess-
ing et al., 1984). This was the first evidence that an autocrine
mechanism of cell growth occurred in human bladder cancer.
The increased colony forming efficiencies of clones B12, Cl
and D2, and UCRU BL 17CL in the presence of UCRU BL
17CL conditioned medium suggests that the parent cell line is
Table II Lectin binding to UCRU BL 17CL cell lines
Cell line WGA PNA MPA SBA UEA ConA
UCRU BL 17CL + + + + ++++ + + + +* + + + +
B8 +++ + +++ + ++ -
B9 + ++ + +++ + +- + + + + + + + +
B12 + + + + + +++ ++ + + + ++
B10, B11, C1, C3, C10, D2 + ++ + +++ + +-++ ++
Binding intensity was quantified as the difference in peak channel fluorescence in the absence and in the presence ofthe
inhibiting sugar. 0-10 channels, -; 11-20 channels, +; 21 -40 channelschannels, + +; 41 -60channels, + + +; >60
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Figure 3 Representative lectin binding profiles obtained by flow cytometric analysis of the cells in the presence of an inhibiting
sugar (broken curve) and in the absence of the sugar (solid curve). a, SBA binding profiles of i, UCRU BL 17CL; ii, clone BI 1; iii,
clone B12. b, UEA binding profiles of i, UCRU BL 17CL; ii, clone B9; iii, clone CIO. c, ConA binding profiles of i, UCRU BL 17CL; ii, clone B9; iii, clone B12.
secreting a growth factor which enhances the ability of only
some of the cells to exhibit anchorage independent growth.
This system may represent another example of the autocrine
growth stimulation of bladder cancer cells.
The response pattern of the clones to the putative growth
factor appears to correlate with a pattern of tumour progres-
sion. The clones which are not tumorigenic in nude mice are,
however, immortal in vitro; they do not respond to the
putative growth factor. Three of the clones which are
tumorigenic in the nude mice do respond; by contrast, those
with high colony forming efficiencies have no response to the
factor. It is of interest that local invasion was seen in one of
five injected mice for each of the latter three clones. Whether
the progression of the cells from an immortal, benign state
through to a malignant, more aggressive phenotype is linked
to their response to the putative growth factor is unknown.
The situation may parallel that found in small cell lung
cancer (SCLC), in which the production and response to
peptide hormones by the cells has been found in pure SCLC
(Little et al., 1983). However, morphological and biochemical
variants of SCLC which do not express the peptide hormones
have also been characterised. These variants have a higher
colony forming efficiency and an incresed tumorigenicity in
athymic nude mice, as well as a poorer prognosis for the
patient when compared to pure SCLC (Little et al., 1983).
The putative growth factor secreted by UCRU BL 17CL is
currently under investigation.
The monoclonal antibody CaOvl has recently been shown
to bind a platelet Gp Ia, which is related to the collagen
receptor (K.Z. Walker & G. Hayden, unpublished results).
The loss of expression of the CaOvl antigen by the UCRU
BL 17CL cell lines might reflect the prolonged growth of
these cells in the absence of collagen. It would be expected
that the selection of cells positive for the CaOvl antigen from
a cell population with a mixed expression pattern would bias
the system towards homogeneity rather than heterogeneity.
In contrast, a heterogeneous series of cell lines were estab-
lished perhaps indicating the extent of the heterogeneity of
some human bladder cancers.
Although there is evidence that continued growth in vitro
can lead to phenotypic instability, the parameters of this
study have remained constant over 40 passages. In vitro
models of human cancers are not completely representative
of the original tumour. However, the in vitro mechanisms of
tumorigenicity, tumour progression, heterogeneity and
differentiation, and the autocrine stimulation of'growth of
tumour cells must parallel the situation in vivo. The UCRU
BL 17CL series of cloned cell lines described in this report
represents a unique model for the study of the biology of
human bladder cancer and illustrates the extent of cellular
heterogeneity found in this type of cancer. When these lines
are studied under the same growth conditions the in vitro
problems of cell selection and instability noted by others
(Heppner, 1984; Masters et al., 1986) are avoided, and com-
parisons can be made within the model.
The parent cell line, UCRU BL 17CL, appears to secrete a
putative growth factor for bladder cancer cells. The clones
show different levels of responsiveness to the factor and also
display a range of tumorigenicity in the nude mouse model.
These characteristics of the URCU BL 17CL series of cloned
cell lines indicate that this system provides a basis for the
study of the autocrine growth stimulation of bladder cancer,
as well as of the tumorigenicity, tumour progression and
heterogeneity of bladder cancer cell populations. The
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Figure 5 Photomicrographs showing the invasive properties ofa,
clone B9; and b, clone B10. Oc = osteoclast; m = residual muscle
bundle.
Figure 4 Photomicrographs of haematoxylin and eosin stained
sections of xenografts of the UCRU BL 17CL cell lines. a, clone
B1O showed predominately squamous differentiation; b, clone
B12 showed predominately glandular differentiation; c, UCRU
BL 17CL showed elements of both squamous and glandular
differentiation.
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differentiation characteristics of the clones suggest that this
model will also be useful in the analysis of the differentiation
pathways in the urothelium. Investigations into these indices
of tumour biology, and the molecular characterisation of the
UCRU BL 17CL system are currently under way in our
laboratory.
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